WARRANT TO PURCHASE SHARES OF COMMON STOCK OFBellerophon Therapeutics, Inc. • September 27th, 2017 • Pharmaceutical preparations • New York
Company FiledSeptember 27th, 2017 Industry JurisdictionThis Warrant is issued to [ ], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of September 26, 2017, among Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
FORM OF WARRANTCaladrius Biosciences, Inc. • May 5th, 2016 • Services-misc health & allied services, nec • New York
Company FiledMay 5th, 2016 Industry JurisdictionThis Warrant is issued to [________]1 Name of Warrant holder., or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 10, 2016, among Caladrius Biosciences, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.